ZYNYZ (retifanlimab-dlwr)

**Product type:** Human Prescription Drug

**Active ingredient:** RETIFANLIMAB

**Strength:** 25 mg/mL

**Dosage form:** Injection

**Route:** Intravenous

**Labeler:** Incyte Corporation

**Marketing category:** BLA (BLA761334)

**Pharmacologic class:** Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]